Diomics

About:

Diomics is focused on the development of therapeutic applications for Diomat polymer for cell therapy.

Description:

Diomics focused on the development of therapeutic applications for Diomat polymer including biomaterial implants for cell therapy and transdermal drug delivery applications. As a life science discovery and development continue to move toward a better understanding of biological responses to disease, the need for high-throughput, quality sample preparation and analysis becomes even more critical. That's why Diomics is committed to providing innovative automation solutions through its materials and technologies that will lead the way to remarkable life science discoveries. It was founded in 2009 and is headquartered in Carlsbad, California.

Total Funding Amount:

$2.96M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Carlsbad, California, United States

Founded Date:

2009-01-01

Founders:

Kirk Avery

Number of Employees:

11-50

Last Funding Date:

2014-10-01

IPO Status:

Private

Industries: